Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Stopped This study was canceled before enrollment due to a decision by the Sponsor

Conditions

• Coronavirus Infections
• SARS-CoV 2
• SARS (Severe Acute Respiratory Syndrome)
• Pulmonary Disease

Interventions

• DRUG: Hydroxychloroquine Sulfate
• DRUG: Hydroxychloroquine Sulfate + Azythromycin

Sponsor

Apsen Farmaceutica S.A.

Collaborators

• [object Object]